Phibro Animal Health (PAHC) Tops Q4 EPS by 8c, provides guidance

Phibro Animal Health (NASDAQ: PAHC) reported Q4 EPS of $0.41, $0.08 better than the analyst estimate of $0.33. Revenue for the quarter came in at $273.2 million versus the consensus estimate of $260.49 million.

GUIDANCE:

Phibro Animal Health sees FY2025 EPS of $1.22-$1.37, versus the consensus of $1.24. Phibro Animal Health sees FY2025 revenue of $1.04-1.09 billion, versus the consensus of $1.029 billion.

For earnings history and earnings-related data on Phibro Animal Health (PAHC) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Full Circle Lithium closes $5.14M private placement
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49